V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20208931 | 20077931 | 1.75 | 114.6 | null | 2018-07-12 | 2018-07-21 | CAPECITABINE + CARBOPLATIN | 02 | null | TRIAL UNSPECIFIED | 100861329 |
| 20208937 | 20077932 | 1.61 | 58 | Neo-adjuvant (N) | 2020-01-21 | 2020-02-02 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101398429 |
| 20208939 | 20077933 | 1.64 | 53.1 | Palliative (P) | 2018-11-02 | 2018-11-03 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 101239018 |
| 20208941 | 20077934 | 1.61 | 79.05 | Palliative (P) | 2019-09-22 | 2019-09-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101029518 |
| 20208946 | 20077935 | 1.7 | 74 | Palliative (P) | 2016-11-28 | 2016-11-29 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100010411 |
| 20208956 | 20077936 | 1.42 | 66.2 | Curative (C) | 2016-04-13 | 2016-04-27 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100920916 |
| 20208957 | 20077937 | 0 | 0 | Palliative (P) | 2020-07-28 | 2020-08-07 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100076563 |
| 20208962 | 20077938 | null | 64.35 | 03 | 2017-12-13 | 2018-01-18 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101808595 |
| 20208965 | 20077939 | 0 | 0 | Curative (C) | 2018-07-21 | 2018-08-11 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100929597 |
| 20208967 | 20077940 | 1.71 | 103.7 | Adjuvant (A) | null | 2018-05-02 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100760999 |
| 20208973 | 20077941 | 1.69 | 56.65 | null | 2019-12-10 | 2019-12-10 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101665751 |
| 20208977 | 20077942 | null | 90 | null | null | 2016-04-18 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100129446 |
| 20208981 | 20077943 | 1.84 | 86.8 | Neo-adjuvant (N) | 2019-06-27 | 2019-08-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101092918 |
| 20208988 | 20077944 | 1.78 | 102.6 | Neo-adjuvant (N) | 2016-02-25 | 2016-03-11 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100280266 |
| 20208990 | 20077945 | 1.62 | 78 | Palliative (P) | 2016-08-05 | 2016-08-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100874851 |
| 20208992 | 20077946 | 0 | 0 | Neo-adjuvant (N) | 2016-07-16 | 2016-08-20 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101311047 |
| 20208993 | 20077947 | 1.74 | null | Palliative (P) | 2019-06-14 | 2019-06-16 | CAPECITABINE + CARBOPLATIN | N | N | TRIAL UNSPECIFIED | 100262930 |
| 20208995 | 20077948 | null | 87.7 | Curative (C) | 2016-11-25 | 2016-12-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101485433 |
| 20209005 | 20077949 | 1.54 | 58 | Palliative (P) | 2017-06-27 | 2017-06-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101086256 |
| 20209006 | 20077950 | 1.71 | 76.5 | Curative (C) | 2018-03-24 | 2018-04-08 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100681305 |
| 20209011 | 20077951 | 1.62 | null | Curative (C) | 2016-08-14 | 2016-09-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100940936 |
| 20209012 | 20077952 | 1.61 | 93.5 | Palliative (P) | 2018-02-12 | 2018-02-12 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101491388 |
| 20209013 | 20077953 | null | null | Palliative (P) | 2016-08-01 | 2016-08-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101867266 |
| 20209015 | 20077954 | null | 67 | Curative (C) | 2016-04-21 | 2016-05-12 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101790827 |
| 20209016 | 20077955 | 1.88 | 66 | Curative (C) | 2018-08-30 | 2018-09-16 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100962640 |
| 20209017 | 20077956 | 1.82 | 86.05 | Palliative (P) | 2016-05-31 | 2016-07-01 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101853257 |
| 20209018 | 20077957 | 1.71 | 40.6 | Palliative (P) | 2017-02-14 | 2017-03-08 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101676703 |
| 20209023 | 20077958 | null | null | Palliative (P) | 2019-10-08 | 2019-11-12 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101451220 |
| 20209034 | 20077959 | 1.72 | null | null | 2017-04-15 | 2017-05-14 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100927072 |
| 20209036 | 20077960 | 1.62 | 58 | null | 2016-05-04 | 2016-06-05 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100919069 |
| 20209041 | 20077961 | 1.67 | 59.25 | Neo-adjuvant (N) | 2020-09-18 | 2020-09-29 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100383005 |
| 20209045 | 20077962 | 1.56 | 63.2 | Curative (C) | null | 2020-01-25 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101263625 |
| 20209051 | 20077963 | 1.7 | 54.6 | Palliative (P) | 2017-06-16 | 2017-07-01 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100045030 |
| 20209052 | 20077964 | 1.7 | 69.4 | Neo-adjuvant (N) | 2016-12-21 | 2016-12-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100580144 |
| 20209054 | 20077965 | 1.68 | 61 | Neo-adjuvant (N) | 2020-05-31 | 2020-06-04 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100625375 |
| 20209058 | 20077966 | 0 | 0 | Curative (C) | 2020-12-16 | 2020-12-16 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100798461 |
| 20209062 | 20077967 | 0 | 0 | Palliative (P) | 2018-02-01 | 2018-02-01 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101205426 |
| 20209073 | 20077968 | 1.61 | 59.35 | Palliative (P) | 2019-11-10 | 2019-11-10 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 101387283 |
| 20209083 | 20077969 | 1.65 | 87.4 | Palliative (P) | 2018-12-14 | 2018-12-14 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101750873 |
| 20209093 | 20077970 | null | 69.7 | Adjuvant (A) | 2018-06-21 | 2018-07-08 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 101297447 |
| 20209106 | 20077971 | 1.75 | 64 | null | 2017-07-15 | 2017-07-15 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100858845 |
| 20209108 | 20077972 | 1.78 | 89.35 | null | 2019-03-29 | 2019-03-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100796755 |
| 20209112 | 20077973 | 1.75 | 82.1 | Neo-adjuvant (N) | 2016-10-31 | 2016-10-31 | Capecitabine (21days) + Carboplatin | 2 | N | CAPECITABINE + CARBOPLATIN | 100504957 |
| 20209113 | 20077974 | 1.53 | 83 | Palliative (P) | 2019-12-17 | 2019-12-21 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100810022 |
| 20209119 | 20077975 | 0 | 0 | null | 2019-03-30 | 2019-05-13 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100587899 |
| 20209124 | 20077976 | null | 70.9 | Palliative (P) | 2016-04-29 | 2016-06-24 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101838732 |
| 20209127 | 20077977 | 1.77 | 118 | Neo-adjuvant (N) | 2019-05-09 | 2019-05-10 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100563892 |
| 20209128 | 20077978 | 1.57 | 71 | 03 | null | 2016-12-29 | Capecitabine (21days) + Carboplatin | 02 | null | CISPLATIN + FLUOROURACIL | 100141653 |
| 20209130 | 20077979 | 1.73 | 54.2 | Neo-adjuvant (N) | 2017-07-13 | 2017-07-13 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 100839148 |
| 20209136 | 20077980 | 1.91 | 52.3 | Palliative (P) | 2018-06-05 | 2018-06-12 | CAPECITABINE + CARBOPLATIN | N | N | CISPLATIN + FLUOROURACIL | 101455600 |